What is Caidya?
Caidya operates as a global clinical research organization, dedicated to supporting innovators across the pharmaceutical and biotechnology industries. The company provides a comprehensive suite of clinical services, leveraging deep therapeutic expertise and proprietary technology to manage clinical trials from pre-IND strategy through to post-marketing surveillance. Caidya's commitment to delivery excellence and an elevated customer experience positions it as a key partner for companies navigating complex drug development pathways. The firm's focus on transparency and data-driven decision-making through its industry-leading technology aims to optimize trial outcomes and accelerate the path to market for novel therapeutics.
How much funding has Caidya raised?
Caidya has raised a total of $297.8M across 14 funding rounds:
Debt
$13M
Debt
$3M
Debt
$4M
Private Equity
$50M
Private Equity
$3.7M
Debt
$3M
Private Equity
$10M
Debt
$18.4M
Debt
$2M
Other Financing Round
$165M
Debt (2012): $13M, investors not publicly disclosed
Debt (2014): $3M with participation from Undisclosed
Debt (2014): $4M, investors not publicly disclosed
Private Equity (2015): $50M supported by Crestline Investors, Inc., Hatteras Venture Partners, and Virgo Investment Group, LLC
Private Equity (2016): $3.7M, investors not publicly disclosed
Debt (2017): $3M backed by Undisclosed
Private Equity (2017): $10M, investors not publicly disclosed
Debt (2020): $18.4M, investors not publicly disclosed
Debt (2020): $2M supported by PPP
Other Financing Round (2025): $165M featuring Rubicon Founders
Key Investors in Caidya
Crestline Investors, Inc.
Crestline Investors, Inc. is an investment firm that typically engages in providing capital solutions. Their involvement suggests a strategic financial backing for Caidya's growth initiatives.
Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm focused on early-stage healthcare and technology companies. Their participation indicates confidence in Caidya's innovative approach and market potential.
Virgo Investment Group, LLC
Virgo Investment Group, LLC is an investment firm that provides capital to companies across various sectors. Their backing of Caidya points to a strategic financial partnership aimed at supporting the company's expansion.
What's next for Caidya?
With the recent influx of major strategic investment and a substantial total funding amount, Caidya is poised for accelerated growth and enhanced service capabilities. This capital infusion is likely to be directed towards expanding its technological infrastructure, broadening its therapeutic area coverage, and potentially increasing its global operational footprint. The company's strategic positioning as a CRO focused on delivery excellence suggests a continued emphasis on client partnerships and the successful execution of complex clinical development programs. Future developments may include strategic acquisitions or deeper integration of its proprietary technologies to further differentiate its offerings in the competitive CRO landscape.
See full Caidya company page
